Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPI ASM8 in Allergic Asthma
NCT00822861Phase 2Completed
- Sponsor
- Syntara Limited
- Start
- Apr 2009
- Primary completion
- Feb 2010
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of ASM8 in allergic asthma, sponsored by Syntara Limited. Started Apr 2009; status: completed.
02
Drugs
ASM8
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00822861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822861.